Plain-English translation of NCT01604395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study of Eutropin (a growth hormone medication) given by injection to children who have trouble growing due to various medical conditions. Researchers want to understand how safe this medication is and how well it helps children grow over many years. The study will follow thousands of children to collect real-world information about the treatment's benefits and any side effects.
Growth hormone treatment helps many children grow taller, but doctors need to understand the long-term safety and effectiveness of this medication when used over years. This study gathers that important information to make sure the treatment continues to be safe and truly helps children reach healthy heights.
You likely qualify if…
You likely don't qualify if…
You would receive growth hormone injections as prescribed by your doctor while researchers track your growth, health, and any side effects over a long period. The study will include clinic visits where your height, weight, and overall health are measured and recorded. Because this is an observational study, researchers are mainly watching and documenting how the treatment works in real-world care rather than testing a brand-new approach.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
South Korea
Sponsor
LG Chem
Enrollment target
~6,000 participants
Started
January 2012
Primary completion
December 2032
Age range
2 Years and older
Last updated on clinicaltrials.gov in February 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
YoungHwan Jang
Kangnam severance hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.